Results 11 to 20 of about 4,120 (178)
The role of the 3'UTR region in the regulation of the ACVR1/Alk-2 gene expression. [PDF]
BACKGROUND: The ACVR1/Alk-2 gene, encoding a BMP type I receptor, is mutated in Fibrodysplasia Ossificans Progressiva, a severe form of heterotopic ossification. Regulation of ACVR1/Alk-2 expression, still poorly understood, is likely to be controlled by
Marzia Mura +4 more
doaj +1 more source
Neofunction of ACVR1 in fibrodysplasia ossificans progressiva [PDF]
Significance By utilizing patient-specific induced pluripotent stem cells (iPSCs) of fibrodysplasia ossificans progressiva (FOP) and gene-corrected (rescued) FOP-iPSCs, we discovered a novel mechanism in ectopic bone formation: The disease-causing mutation endows ACVR1 with the ability to transmit the signal of an unexpected ligand ...
Kyosuke, Hino +10 more
openaire +2 more sources
Fibrodysplasia ossificans progressiva (FOP) is a rare human genetic disorder characterized by altered skeletal development and extraskeletal ossification.
Robyn S Allen +3 more
doaj +1 more source
ACVR1 (activin A receptor, type I) [PDF]
Review on ACVR1 (activin A receptor, type I), with data on DNA, on the protein encoded, and where the gene is implicated.
Rainho, CA, Rogatto, SR
openaire +2 more sources
Variable signaling activity by FOP ACVR1 mutations [PDF]
Most patients with fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder of heterotopic ossification, have the same causative mutation in ACVR1, R206H. However, additional mutations within the ACVR1 BMP type I receptor have been identified in a small number of FOP cases, often in patients with disease of lesser or greater severity than ...
Julia, Haupt, Meiqi, Xu, Eileen M, Shore
openaire +2 more sources
Fibrodysplasia ossificans progressiva: current concepts from bench to bedside
Heterotopic ossification (HO) is a disorder characterised by the formation of ectopic bone in soft tissue. Acquired HO typically occurs in response to trauma and is relatively common, yet its aetiology remains poorly understood.
Arun-Kumar Kaliya-Perumal +2 more
doaj +1 more source
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis
Activin receptor type I (ACVR1) is a transmembrane kinase receptor belonging to bone morphogenic protein receptors (BMPs). ACVR1 plays an important role in hematopoiesis and anemia via the BMP6/ACVR1/SMAD pathway, which regulates expression of hepcidin, the master regulator of iron homeostasis.
Andrea Duminuco +5 more
openaire +3 more sources
Single-cell omics reveals the role of ACVR1 in odontoblastic differentiation [PDF]
Objective To investigate the impact of activin receptor type-1 (ACVR1) on odontoblastic differentiation and dentin formation based on single-cell RNA sequencing. Methods A correlation analysis of ACVR1 with odontogenesis-related transcription factors was
SONG Shaoyi, LIU Cangwei, SHI CE, LIU Qilin, SUN Hongchen
doaj +1 more source
Activin A functions in BMP signaling in two ways: it either engages ACVR1B to activate Smad2/3 signaling or binds ACVR1 to form a non-signaling complex (NSC).
Senem Aykul +19 more
doaj +1 more source
Modeling the ACVR1R206H mutation in human skeletal muscle stem cells
Abnormalities in skeletal muscle repair can lead to poor function and complications such as scarring or heterotopic ossification (HO). Here, we use fibrodysplasia ossificans progressiva (FOP), a disease of progressive HO caused by ACVR1R206H (Activin ...
Emilie Barruet +7 more
doaj +1 more source

